Briseño HH

Language: Spanish
References: 8
Page: 1-7
PDF size: 348.91 Kb.

ABSTRACT

Background: High-grade cervical intraepithelial lesions are recommended to perform epidemiological studies and case reports according to the Mexican Official Norm 014. . The guidelines of the American Society for Colposcopy and Cervical Pathology suggested in the post treatment of CIN 2-3 perform HPV DNA testing or annual or semiannual cytology alone or a combination of cytology with colposcopy every six months. Objective and Methods: Report management and clinical course of five patients CIN 2 + from colposcopy Unit of General Hospital of Zapopan and international literature review. We applied the recommendations of current guidelines. Results: The frequency of residual lesion increases when there is a greater extent of lesion, age above 30 years and endocervical involvement. Conclusions: The cytological screening and colposcopic semiannual and annual testing of HPV DNA confer a safe and reliable monitoring of CIN 2 + post cervical conization.

REFERENCES

1. NOM-014-SSA2-1994, para la Prevención, Detección, Diagnóstico, Tratamiento, Control y Vigilancia Epidemiológica del Cáncer Cérvico Uterino. Modificada el 31 de mayo de 2007, Diario Oficial de la Federación.

2. NOM-017-SSA2-1994, Para la vigilancia epidemiológica, 17 de noviembre de 1994, Diario Oficial de la Federación.

3. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D for the 2006 consensus guidelines for the management of women with cervical intraepitelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007, 11 (4):223-39.

4. Arbyn M, Paraskevaidis E, Prendiville W. Gynecol Oncol 2005; 99(3) S7-11.

5. Zielinsky GD. Obstat Gynecol Survey 2004;59(7):543-53.

6. Leguevaque P, Motton S. Eur J Surg Oncol. 2010 Nov;36 (11):1073-9.

7. Mitchell MF. Obstet Gynecol 1998;92:737-44.

8. Paraskevaidis E, Koliopoulos G. Obstet Gynecol 2001; 98:833